Form 10-K Item 1C cybersecurity disclosure from a pharmaceutical company describing its cybersecurity risk-management program, governance, and use of third-party IT consultants. The filing affirmatively states that no cybersecurity incident or aggregation of incidents has materially affected the company's results of operations or financial condition to date. No specific breach is disclosed.